ERAXIS
As listed in the register: ERAXIS
100 mg · powder for solution
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Anidulafungin
- Made by
- Pfizer Canada Ulc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ERAXIS). It describes the substance, not this exact product.
Anidulafungin is an anti-fungal drug [see Microbiology (12.4) ].
It is unlikely that anidulafungin will have clinically relevant effects on the metabolism of drugs metabolized by CYP450 isoenzymes.
Approximately 30% of the administered radioactive dose was eliminated in the feces over 9 days, of which less than 10% was intact drug.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-08-19
Safety of the active substance
From the US prescribing label for the same active substance (ERAXIS). It describes the substance, not this exact product.
- ERAXIS is contraindicated in:.
- Patients with known hypersensitivity to anidulafungin, any component of ERAXIS, or other echinocandins [see Warnings and Precautions (5.2) ].
- Patients with known or suspected Hereditary Fructose Intolerance (HFI) [see Warnings and Precautions (5.4) ].
- Known hypersensitivity to anidulafungin, any component of ERAXIS, or other echinocandins ( 4, 5.2 ).
Most common adverse reactions (≥15%) are hypokalemia, nausea, diarrhea, vomiting, pyrexia, insomnia, hypotension.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pfizer Canada Ulc |
|---|---|
| Active substance | Anidulafungin |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 100 mg |
| Form | powder for solution |
| Classification | J02AX06 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02330695 |
| DPD drug code | 81644 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.